Atlanta Consulting Group Advisors’s Pfizer PFE Stock Holding History

Atlanta Consulting Group Advisors’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$385K	Sell	13,709 -78	-0.6%	-$2.08K	0.08%	102
2025 Q4	$343K	Buy	13,787 +970	+8%	+$24.5K	0.08%	115
2025 Q3	$327K	Hold	12,817	–	–	0.08%	104
2025 Q2	$311K	Sell	12,817 -204	-2%	-$4.76K	0.09%	102
2025 Q1	$330K	Sell	13,021 -49	-0.4%	-$1.28K	0.1%	88
2024 Q4	$347K	Sell	13,070 -33,716	-72%	-$915K	0.13%	90
2024 Q3	$1.35M	Buy	46,786 +34,293	+274%	+$1M	0.34%	55
2024 Q2	$350K	Buy	12,493 +1,060	+9%	+$29.2K	0.08%	86
2024 Q1	$317K	Buy	+11,433	New	+$317K	0.11%	97

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Atlanta Consulting Group Advisors's PFE Position: Q1 2026 in Review

Atlanta Consulting Group Advisors reduced its Pfizer (PFE) stake by 0.57% in Q1 2026, selling an estimated $2.08K and leaving 13,709 shares worth $385K. The position accounts for 0.08% of the portfolio, ranked #102.

Atlanta Consulting Group Advisors first reported a position in PFE in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.35M in Q3 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Atlanta Consulting Group Advisors held 13,709 shares of Pfizer worth $385K as of Q1 2026.
Atlanta Consulting Group Advisors sold 78 Pfizer shares in Q1 2026, an estimated $2.08K.
Pfizer made up 0.08% of Atlanta Consulting Group Advisors's portfolio in Q1 2026, its #102 holding.
Atlanta Consulting Group Advisors first reported a position in Pfizer in Q1 2024 and has held it in 9 quarters since.
Atlanta Consulting Group Advisors's Pfizer position peaked at $1.35M in Q3 2024.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Atlanta Consulting Group Advisors's 13F filing for Q1 2026, filed 15 May 2026.